Francesc Muyas

Oncology R&D, AstraZeneca Cambridge Biomedical Campus
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy.

Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy.

Journal: Journal for immunotherapy of cancer
Published: April 15, 2026

GeneBits: ultra-sensitive tumour-informed ctDNA monitoring of treatment response and relapse in cancer patients.

GeneBits: ultra-sensitive tumour-informed ctDNA monitoring of treatment response and relapse in cancer patients.

Journal: Journal of translational medicine
Published: May 14, 2025

A tumour-derived organoid biobank maps cancer gene dependencies.

A tumour-derived organoid biobank maps cancer gene dependencies.

Journal: Nature
Published: February 06, 2025

scAI-SNP: a method for inferring ancestry from single-cell data.

scAI-SNP: a method for inferring ancestry from single-cell data.

Journal: BMC methods
Published: September 26, 2024

SAVANA: reliable analysis of somatic structural variants and copy number aberrations using long-read sequencing.

SAVANA: reliable analysis of somatic structural variants and copy number aberrations using long-read sequencing.

Journal: Nature methods
Published: August 06, 2024

scAI-SNP: a method for inferring ancestry from single-cell data.

scAI-SNP: a method for inferring ancestry from single-cell data.

Journal: bioRxiv : the preprint server for biology
Published: May 27, 2024

Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution.

Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution.

Journal: Cell
Published: March 29, 2024

Predicting response to immune checkpoint blockade therapy among mismatch repair-deficient patients using mutational signatures.

Predicting response to immune checkpoint blockade therapy among mismatch repair-deficient patients using mutational signatures.

Journal: medRxiv : the preprint server for health sciences
Published: January 31, 2024

Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition.

Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition.

Journal: Nature communications
Published: November 23, 2023

A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization.

A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization.

Journal: Cancer cell
Published: July 05, 2023

Specialized replication mechanisms maintain genome stability at human centromeres.

Specialized replication mechanisms maintain genome stability at human centromeres.

Journal: Molecular cell
Published: March 13, 2023

Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity.

Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity.

Journal: Nature genetics
Published: March 09, 2023
Showing 1-12 of 23

Last Updated: 09/26/2026